David A DeGoey (David DeGoey)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 8

Top Topics

Emergency Department

Prostate Cancer

Top Venues

Journal of medicinal chemistry

Chemical science

Journal of the American Chemical Society

This page only lists publications with an associated author ORCID identifier.

Publications

Edward Price, Manuel Weinheimer, Alexey Rivkin, Gary Jenkins, Marjoleen Nijsen, Philip B Cox, David A DeGoey
Beyond Rule of Five and PROTACs in Modern Drug Discovery: Polarity Reducers, Chameleonicity, and the Evolving Physicochemical Landscape. Journal of medicinal chemistry (2024)
Edward Price, Manuel Weinheimer, Alexey Rivkin, Gary Jenkins, Marjoleen Nijsen, Philip B Cox, David A DeGoey
Beyond Rule of Five and PROTACs in Modern Drug Discovery: Polarity Reducers, Chameleonicity, and the Evolving Physicochemical Landscape. Journal of medicinal chemistry 67 (7) (2024)
Edward Price, Manuel Weinheimer, Alexey Rivkin, Gary Jenkins, Marjoleen Nijsen, Philip B Cox, David A DeGoey
Beyond Rule of Five and PROTACs in Modern Drug Discovery: Polarity Reducers, Chameleonicity, and the Evolving Physicochemical Landscape. Journal of medicinal chemistry 67 (7) (2024)
Ahmad Y Sheikh, Alessandra Mattei, Rajni Miglani Bhardwaj, Richard S Hong, Nathan S Abraham, Gabriela Schneider-Rauber, Kenneth M Engstrom, Moiz Diwan, Rodger F Henry, Yi Gao, Vivian Juarez, Erin Jordan, David A DeGoey, Charles W Hutchins
Implications of the Conformationally Flexible, Macrocyclic Structure of the First-Generation, Direct-Acting Anti-Viral Paritaprevir on Its Solid Form Complexity and Chameleonic Behavior. Journal of the American Chemical Society 143 (42) (2021)
Edward Price, J Cory Kalvass, David A DeGoey, Balakrishna Hosmane, Stella Doktor, Kelly Desino
Global Analysis of Models for Predicting Human Absorption: QSAR, In Vitro, and Preclinical Models. Journal of medicinal chemistry 64 (13) (2021)
Eric A Voight, Stephen N Greszler, John Hartung, Jianguo Ji, Russell C Klix, John T Randolph, Bhadra H Shelat, Jan E Waters, David A DeGoey
Desymmetrization of pibrentasvir for efficient prodrug synthesis. Chemical science 12 (29) (2021)
John T Randolph, Eric A Voight, Stephen N Greszler, Brice E Uno, James N Newton, Kenneth M Gleason, DeAnne Stolarik, Cecilia Van Handel, Daniel A J Bow, David A DeGoey
Prodrug Strategies to Improve the Solubility of the HCV NS5A Inhibitor Pibrentasvir (ABT-530). Journal of medicinal chemistry 63 (19) (2020)
David A DeGoey, Hui-Ju Chen, Philip B Cox, Michael D Wendt
Beyond the Rule of 5: Lessons Learned from AbbVie's Drugs and Compound Collection. Journal of medicinal chemistry 61 (7) (2017)